Advanced Micro Devices, Inc. (AMD)
AMD's Pullback Won't Last Long (Rating Upgrade)
Advanced Micro Devices is shifting from standalone accelerators to rack-scale MI450 and Helios systems, increasing value capture per AI deployment. Fifth-generation EPYC drove over half of server revenue in Q4, positioning CPUs as an AI demand multiplier. Consensus projects revenue growth from $46.4B in 2026 to $64.4B in 2027, implying 39% expansion.
Advanced Micro Devices, Inc. (AMD) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Advanced Micro (AMD). This makes it worthwhile to examine what the stock has in store.
ChatGPT picks 2 stocks to buy during the February tech sell-off
The February 2026 big tech sell-off has rattled investors with Microsoft (NASDAQ: MSFT) and Advanced Micro Devices (NASDAQ: AMD), posting sharp post-earnings declines.
Wall Street sets AMD stock price target for next 12 months
Advanced Micro Devices (NASDAQ: AMD) has been hit hard by the early 2026 sell-off and is down 13.92% in the stock market in the last 30 days.
AMD Stock: $300 Appears Imminent; Why I'm Buying More
Advanced Micro Devices, Inc. shares are fading in the wake of earnings. AMD stock is down more than 20% since last month's highs. Strong AI infrastructure demand will lift AMD's operating results.
Did Nvidia Just Deliver a Crushing Blow to AMD?
Advanced Micro Devices ( NASDAQ:AMD | AMD Price Prediction ) has been advancing its AI chip offerings, including the Instinct MI450 series accelerators set for deployment with OpenAI starting in the second half of 2026.
What Will Power AMD Stock's Next Rally?
AMD has a solid track record of substantial rallies. The stock has increased by over 50% within two months on several occasions, particularly in 2013 and 2021, offering significant profits for its investors.
Ocular: 'Buy' As AXPAXLI Program For Wet-AMD Moves To Potential NDA Filing
Ocular Therapeutix maintains a "Buy" rating, driven by strong phase 3 SOL-1 data for AXPAXLI in wet-AMD and upcoming regulatory catalysts. AXPAXLI demonstrated statistically significant superiority over low-dose EYLEA, with 74.1% of patients maintaining vision at 36 weeks versus 55.8% for EYLEA. Key near-term catalysts include an FDA meeting on SOL-1 data and potential NDA filing, with further data from the SOL-R trial expected in Q1 2027.
Here's Why Advanced Micro Devices (AMD) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors
Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exceptional Corporate Resilience profile and attractive sustainability opportunity set in areas like the Digital Infrastructure build-out. Oracle stands out with a strong sustainability profile, offering notable opportunities in Digital Infrastructure, Education and the development of Enhanced Skills & Innovation.
Better Artificial Intelligence Stock: Nvidia vs. AMD
Nvidia remains the undisputed leader of GPUs. AMD has a big opportunity with inference.
Nvidia's stock is down and AMD is up. The culprit may be Arista.
Shares of Nvidia fell on Friday, while rival Advanced Micro Devices rallied after Arista Networks CEO Jayshree Ullal said her company is shifting some workloads. Ullal said that a year ago about 99% of deployments were Nvidia, and now about 20% to 25% use AMD.
